Keveyis Interactions
There are 229 drugs known to interact with Keveyis (dichlorphenamide), along with 9 disease interactions. Of the total drug interactions, 22 are major, 202 are moderate, and 5 are minor.
- View all 229 medications that may interact with Keveyis
- View Keveyis disease interactions (9)
Most frequently checked interactions
View interaction reports for Keveyis (dichlorphenamide) and the medicines listed below.
- AccessPak for HIV PEP Expanded with Viracept (emtricitabine / nelfinavir / tenofovir)
- acetazolamide
- Adderall (amphetamine / dextroamphetamine)
- Advate (antihemophilic factor)
- albuterol
- Aldactone (spironolactone)
- amiloride
- Aqua-Ban (pamabrom)
- Aquatensen (methyclothiazide)
- Aquazide H (hydrochlorothiazide)
- Aridol (mannitol)
- Arnuity Ellipta (fluticasone)
- Benadryl (diphenhydramine)
- benzonatate
- bumetanide
- Bumex (bumetanide)
- cannabis
- carbidopa / levodopa
- CaroSpir (spironolactone)
- chlorothiazide
- chlorthalidone
- Claritin (loratadine)
- eplerenone
- famotidine
- gabapentin
- Lyrica (pregabalin)
- midodrine
- Prevacid (lansoprazole)
- Vitamin D3 (cholecalciferol)
- Zofran (ondansetron)
Keveyis disease interactions
There are 9 disease interactions with Keveyis (dichlorphenamide) which include:
- acidosis
- adrenocortical insufficiency
- dehydration
- hepatic disease
- pulmonary disease
- renal dysfunction
- respiratory acidosis
- diabetes mellitus
- gout
Report options
QR code containing a link to this page
More about Keveyis (dichlorphenamide)
- Keveyis consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: carbonic anhydrase inhibitors
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
